Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NVCN
7076
DELISTED
Neovasc Inc.
NVCN
| $20K | ﹤0.01% |
+1
| New | +$37.9K |
2016 Q3
2 quarters
|
|
|
AMPE
7077
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $20K | ﹤0.01% |
84
-22
| -21% | -$5.91K |
2016 Q2
3 quarters
|
|
|
ATHX
7078
CALL
DELISTED
Athersys, Inc. Common Stock
ATHX
| $20K | ﹤0.01% |
+464
| New | +$14.8K |
2017 Q1
0 quarters
|
|
|
WMGIZ
7079
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
| $20K | ﹤0.01% |
+12,377
| New | +$18.8K |
2017 Q1
0 quarters
|
|
|
MSLI
7080
DELISTED
Merus Labs International Inc.
MSLI
| $20K | ﹤0.01% |
21,826
-14,729
| -40% | -$12.7K |
2016 Q2
3 quarters
|
|
|
OHGI
7081
DELISTED
One Horizon Group, Inc.
OHGI
| $20K | ﹤0.01% |
11,757
+1,040
| +10% | +$1.82K |
2016 Q4
1 quarter
|
|
|
FENX
7082
DELISTED
Fenix Parts, Inc.
FENX
| $20K | ﹤0.01% |
+12,659
| New | +$27.9K |
2017 Q1
0 quarters
|
|
|
GCVRZ
7083
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $20K | ﹤0.01% |
44,800
-10,927
| -20% | -$4.8K |
2016 Q2
3 quarters
|
|
7084
Cohen & Co
COHN
$31.6M
| $19K | ﹤0.01% |
+1,673
| New | +$20.9K |
2017 Q1
0 quarters
|
|
7085
Eltek
ELTK
$53.6M
| $19K | ﹤0.01% |
5,524
+926
| +20% | +$3.75K |
2016 Q3
2 quarters
|
|
7086
Neonode
NEON
$15.5M
| $19K | ﹤0.01% |
+1,205
| New | +$19.9K |
2017 Q1
0 quarters
|
|
7087
Arcadia Biosciences
RKDA
$694K
| $19K | ﹤0.01% |
+35
| New | +$25.1K |
2017 Q1
0 quarters
|
|
7088
Tenax Therapeutics
TENX
$74.1M
| $19K | ﹤0.01% |
+1
| New | +$36.3K |
2017 Q1
0 quarters
|
|
|
OPGN
7089
DELISTED
OpGen, Inc
OPGN
| – | – |
0
| – | – |
2016 Q1
4 quarters
|
|
|
NEPT
7090
PUT
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $19K | ﹤0.01% |
14
+4
| +40% | +$5.9K |
2016 Q4
1 quarter
|
|
|
AHPI
7091
DELISTED
Allied Healthcare Products
AHPI
| $19K | ﹤0.01% |
+10,084
| New | +$20.7K |
2017 Q1
0 quarters
|
|
|
AMPE
7092
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $19K | ﹤0.01% |
+78
| New | +$21K |
2017 Q1
0 quarters
|
|
|
AXU
7093
PUT
DELISTED
Alexco Resource Corp
AXU
| $19K | ﹤0.01% |
12,400
-1,000
| -7% | -$1.71K |
2016 Q4
1 quarter
|
|
|
SMTX
7094
DELISTED
SMTC Corporation
SMTX
| $19K | ﹤0.01% |
15,184
+1,500
| +11% | +$2.08K |
2016 Q4
1 quarter
|
|
|
ROYT
7095
PUT
DELISTED
PACIFIC COAST OIL TRUST
ROYT
| $19K | ﹤0.01% |
+10,000
| New | +$15.1K |
2017 Q1
0 quarters
|
|
|
ARDM
7096
DELISTED
Aradigm Corp Common Stock
ARDM
| $19K | ﹤0.01% |
+11,972
| New | +$22.2K |
2017 Q1
0 quarters
|
|
|
SPI
7097
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
| $19K | ﹤0.01% |
162
-31
| -16% | -$4.25K |
2016 Q4
1 quarter
|
|
|
UNIS
7098
CALL
DELISTED
Unilife Corporation
UNIS
| $19K | ﹤0.01% |
+11,000
| New | +$23.1K |
2017 Q1
0 quarters
|
|
|
DRRX
7099
DELISTED
DURECT Corp
DRRX
| $18K | ﹤0.01% |
1,704
-1,870
| -52% | -$20K |
2016 Q2
3 quarters
|
|
7100
CALL
Gevo
GEVO
$324M
| $18K | ﹤0.01% |
805
+779
| +2,996% | +$33K |
2016 Q3
2 quarters
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.